New Jersey-based pharmaceutical company has issued a recall of its infants' liquid ibuprofen after discovering a high concentration of medication in some of it's packages. The company has recalled three lots of "Infants' Ibuprofen Concentrated Oral Suspension, AID)" "There is a remote possibility that infants, who may be more susceptible to a higher potency level of drug, and therefore may be more vulnerable to permanent NSAID-associated renal injury," the statement said. "Adverse effects are nausea, vomiting, epigastric pain, or more rarely, diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible adverse effects."
Content Goes Here